Syngen Biotech Co., Ltd. Reports Earnings Results for the Third Quarter Ended September 30, 2020
October 29, 2020 at 08:08 pm
Share
Syngen Biotech Co., Ltd. announced earnings results for the third quarter ended September 30, 2020. For the third quarter, the company announced sales was TWD 341.056 million compared to TWD 347.908 million a year ago. Operating income was TWD 73.975 million compared to TWD 61.221 million a year ago. Net income was TWD 59.587 million compared to TWD 45.427 million a year ago. Basic earnings per share was TWD 2.2 compared to TWD 1.97 a year ago. For the nine months, sales was TWD 978.864 million compared to TWD 966.261 million a year ago. Operating income was TWD 216.157 million compared to TWD 177.722 million a year ago. Net income was TWD 174.385 million compared to TWD 137.963 million a year ago. Basic earnings per share was TWD 6.43 compared to TWD 5.97 a year ago.
Syngen Biotech Co Ltd is a Taiwan-based company mainly engaged in the manufacture and distribution of active pharmaceutical ingredients and health food products. The Companyâs products mainly consist of active pharmaceutical ingredients, health food raw materials, medical equipment, such as bone density analyzers, blood glucose analyzers and biochemical analyzers, as well as animal health products and others. The Company distributes its products mainly in Taiwan, Iran, South Korea and Egypt.
SYNGEN BIOTECH CO.,LTD. 
